Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...
Cilostazol exhibits its pharmacologic effects via antiplatelet, vasodilatory, and antithrombotic activities. Like pentoxifylline, cilostazol and several of its metabolites exhibit these antiplatelet ...
Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback